Additionally, Nr4a2 has been reported to regulate cardiac fibrosis by inducing autophagic flux and inhibiting apoptosis in myocardial injury associated with metabolic syndrome (MetS) [48]. Here, NR4A2 is linked to metabolic syndrome.